Working… Menu
Trial record 1 of 1 for:    64619178EDI1001 | Germany
Previous Study | Return to List | Next Study

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03573310
Recruitment Status : Recruiting
First Posted : June 29, 2018
Last Update Posted : February 26, 2021
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 8, 2022
Estimated Study Completion Date : July 8, 2022